European Consensus Statement on the diagnosis and management of osteoporosis in chronic kidney disease stages G4–G5D
Pieter Evenepoel(KU Leuven), Goce Spasovski(Ss. Cyril and Methodius University in Skopje), Justine Bacchetta(Université Claude Bernard Lyon 1), Sandro Mazzaferro, Jorge B. Cannata‐Andía(Universidad de Oviedo), Marie‐Hélène Lafage‐Proust(Unknown), Daniel Prieto‐Alhambra(Nuffield Orthopaedic Centre), Marc Vervloet(Radboud University Nijmegen), Mathias Haarhaus(Karolinska Institutet), Syazrah Salam, M K Javaid(Nuffield Orthopaedic Centre), John Cunningham(Centre for Addiction and Mental Health), Patrick C. D’Haese(University of Antwerp), Pablo Ureña‐Torres(Délégation Paris 5), Annibal Ferreira, Serge Ferrari(Hôpital Beau-Séjour)
Cited by 185
Related Papers
Cinacalcet for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis
|New England Journal of Medicine|2004|1.1k
Clinical practice guideline on diagnosis and treatment of hyponatraemia
|Intensive Care Medicine|2014|1k
Executive summary of the 2017 KDIGO Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD) Guideline Update: what’s changed and why it matters
|Kidney International|2017|998
Clinical practice guideline on diagnosis and treatment of hyponatraemia
|European Journal of Endocrinology|2014|823